New patent for Sanofi-aventis Us drug SOLIQUA 100/33

July 14, 2018Comments Off on New patent for Sanofi-aventis Us drug SOLIQUA 100/33 Posted in: Patent Added

Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100/33 appeared first on DrugPatentWatch - Make Better Decisions.